Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Whatever happened to PKU?

C R Scriver1

  • 1Department of Pediatrics, McGill University, Montreal, Canada.

Clinical Biochemistry
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Phenylketonuria (PKU) is a genetic disorder of metabolism. Advances in science and technology have led to successful disease prevention strategies, offering hope for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Commentary on Multiple Screening for Aminoacidopathies in the Newborn Infant.

Canadian Medical Association journal·2010
Same author

Significance of the fellowship examination for canadian medical scientists.

Canadian Medical Association journal·2010
Same author

What we know that could influence future treatment of phenylketonuria.

Journal of inherited metabolic disease·2008
Same author

The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England.

Annals of human genetics·2008
Same author

Recommendations for locus-specific databases and their curation.

Human mutation·2007
Same author

CpG methylation accounts for a recurrent mutation (c.1222C>T) in the human PAH gene.

Human mutation·2006
Same journal

Evaluation of hemoglobin interference thresholds for chemical urinalysis panels.

Clinical biochemistry·2026
Same journal

Integrated genomic and biochemical diagnosis of a novel homozygous start-loss variant in AKR1D1 associated with neonatal cholestasis.

Clinical biochemistry·2026
Same journal

Agreement between POC glucose meters and blood gas analyzers varies across ICU patient populations.

Clinical biochemistry·2026
Same journal

From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting.

Clinical biochemistry·2026
Same journal

Response to the letter to the editor: From variability to value: Advancing vancomycin therapeutic drug monitoring toward decision-grade practice through commutability-informed external quality assessment and uncertainty-aware reporting.

Clinical biochemistry·2026
Same journal

What are the correlates of laboratory productivity in clinical laboratories in the Asia Pacific region?

Clinical biochemistry·2026
See all related articles

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Phenylketonuria (PKU) represents a landmark in understanding inborn errors of metabolism.
  • It serves as a prime example of successful genetic disease prevention through scientific and technological innovation.

Observation:

  • Over 60 years, research has deepened the understanding of PKU's clinical and metabolic phenotypes.
  • Five genes are implicated in phenylalanine hydroxylation and cofactor synthesis, with mutations characterized for key enzymes like PAH.

Findings:

  • The human PAH gene harbors over 170 identified mutations causing hyperphenylalaninemia, primarily loss-of-function.
  • A novel enu mouse model aids research into brain disease pathogenesis and therapeutic development.
  • PKU gene frequency is polymorphic (1%), with stratified mutation distribution suggesting founder effects, genetic drift, and selection.

Related Experiment Videos

Implications:

  • Continued research into PKU pathogenesis and genetics can reveal new therapeutic targets.
  • Understanding mutation distribution provides insights into population genetics and evolutionary mechanisms.
  • The success in PKU prevention highlights the potential for managing other genetic diseases.